Medmeme to become Pharmaspectra

A new company with a broader mission and product set, the name Pharmaspectra better communicates our goal of solving problems across the biopharma spectrum, from drug discovery through post-marketing.

CITATION: PD-L1/PD-1 Inhibitors and Beyond

A peer-reviewed article that appeared in the Journal of Pharmacology and Clinical Research by David Segarnick, PhD and Heather Chien, M.S., explores the current and future landscape of immunotherapy compounds that use the body’s own immune system to fight cancer, citing Medmeme data